Progress Or Hype? Looking At A Decade Of Cell Therapy In Japan
Regulatory Approach Evolving After Challenges
After 10 years of promised investment following its Nobel Prize for iPS cell research, Japan is cautiously narrowing regulations around the conditional approval of cell therapies and cutting reimbursement prices. How has the sector panned out over the last decade?
